aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
miércoles, 4 de septiembre de 2024
Patient Engagement Advisory Committee (PEAC) October 30, 2024 | 10AM- 5PM EST
https://www.fdalive.com/peac/?utm_medium=email&utm_source=govdelivery
Patient-Centered Informed Consent in Clinical Study of FDA-Regulated Medical Products
Meeting Date: Wednesday, October 30, 2024, 10:00 a.m. to 5:00 p.m. ET
Location: Webcast
Registration: Registration is only required to participate in the breakout sessions.
The U.S. Food and Drug Administration (FDA) is announcing the Patient Engagement Advisory Committee (PEAC) meeting, where PEAC will discuss and make recommendations on patient-centered informed consent in clinical study of FDA-regulated medical products. The topics for discussion include:
The informed consent process, and
Factors to consider when communicating informed consent to clinical study participants to increase the likelihood of participants understanding the key elements of research.
No hay comentarios:
Publicar un comentario